Table 1³⁵.

Patients characteristics for 18 total patients, the three groups included infected nonunion (group A), infected nonunion repair (group B), and recurrent osteomyelitis (group C)

	Patient	Age	Segment	Open Fracture	Bacteria	Local Antibiotic
Group A	1	34	Tibia	GIIIB	MRSA/Enterobacter cloacae	Vancomycin/gentamycin
	2	20	Tibia	GIIIB	MRSA/Serratia spp	Vancomycin/tobramycin
	3	26	Tibia	GIIIB	MRSA	Vancomycin/gentamycin
	4	44	Femur	No	MRSA	Vancomycin
	5	36	Tibia	GIIIB	MRSA	Vancomycin/tobramycin
	6	52	Tibia	GIIIA	MRSA	Vancomycin/gentamycin
	7	45	Tibia	GIII A	MRSA	Vancomycin/gentamycin
	8	29	Tibia	GIIIB	MRSA	Vancomycin/gentamycin
	9	18	Femur	No	MRSA	Vancomycin/gentamycin
			Tibia	No	MRSA	Vancomycin/gentamycin
	10	42	Tibia	GIIIA	MSSA*/pseudom	Vancomycin/gentamycin/imipenem
	11	41	Tibia	GIIIB	Pseudomona/MRSA	Vancomycin/gentamycin/colis
Group B	12	20	Tibia	No	MSSA	Vancomycin/gentamycin
	13	34	Tibia	GIIIA	MRSA	Vancomycin
	14	50	Tibia	GII	MRSA	Vancomycin/gentamycin
	15	33	Femur	GIIIA	MRSA	Vancomycin/gentamycin
	16	41	Femur	No	MRSA	Vancomycin/tobramycin
Group C	17	38	Tibia	No	MRSA†	Vancomycin/gentamycin
	18	65	TIBIA	No	MRSA/Enterobacter cloacae	Vancomycin/gentamycin

^*Staphylococcus sensitive to methicillin and Pseudomona aureoginosa.

^†Staphylococcus resistent to methicillin.